Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and mining markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in an environmental remediation business that manages the cleanup of redundant TEL plants. The company serves oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, formulators of personal care and home care, agrochemical and mining formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554
Debt
Debt-to-Equity Ratio0.26
Current Ratio2.28
Quick Ratio1.34
Price-To-Earnings
Trailing P/E Ratio16.46
Forward P/E Ratio17.61
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.31 billion
Price / Sales1.43
Cash Flow$6.8515 per share
Price / Cash11.18
Book Value$32.91 per share
Price / Book2.33
Profitability
EPS (Most Recent Fiscal Year)$4.66
Net Income$61.80 million
Net Margins4.45%
Return on Equity13.83%
Return on Assets7.81%
Miscellaneous
Employees1,900
Outstanding Shares24,420,000
Market Cap$1.86 billion
Innospec (NASDAQ:IOSP) Frequently Asked Questions
What is Innospec's stock symbol?
Innospec trades on the NASDAQ under the ticker symbol "IOSP."
How often does Innospec pay dividends? What is the dividend yield for Innospec?
Innospec declared a semiannual dividend on Wednesday, May 9th. Shareholders of record on Monday, May 21st will be given a dividend of $0.44 per share on Thursday, May 31st. This represents a yield of 1.18%. The ex-dividend date is Friday, May 18th. This is a positive change from Innospec's previous semiannual dividend of $0.39. View Innospec's Dividend History.
How were Innospec's earnings last quarter?
Innospec Inc. (NASDAQ:IOSP) announced its earnings results on Tuesday, August, 7th. The specialty chemicals company reported $1.00 EPS for the quarter, missing analysts' consensus estimates of $1.05 by $0.05. The specialty chemicals company earned $358.10 million during the quarter. Innospec had a return on equity of 13.83% and a net margin of 4.45%. View Innospec's Earnings History.
When is Innospec's next earnings date?
What price target have analysts set for IOSP?
3 equities research analysts have issued 12-month target prices for Innospec's shares. Their forecasts range from $86.00 to $86.00. On average, they expect Innospec's stock price to reach $86.00 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price. View Analyst Price Targets for Innospec.
What is the consensus analysts' recommendation for Innospec?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innospec.
Who are some of Innospec's key competitors?
Some companies that are related to Innospec include Chemours (CC), Huntsman (HUN), Ashland Global (ASH), KURARAY Co Ltd/ADR (KURRY), W. R. Grace & Co (GRA), Olin (OLN), Ingevity (NGVT), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), KMG Chemicals (KMG), Nexeo Solutions (NXEO), OCI Partners (OCIP) and Innophos (IPHS).
Who are Innospec's key executives?
Innospec's management team includes the folowing people:
- Mr. Patrick S. Williams, Pres, CEO & Director (Age 53)
- Mr. Ian P. Cleminson, Exec. VP & CFO (Age 52)
- Dr. Philip J. Boon, COO & Exec. VP (Age 59)
- Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 69)
- Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 59)
Who are Innospec's major shareholders?
Innospec's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.66%), FMR LLC (14.62%), Dimensional Fund Advisors LP (6.14%), Wells Fargo & Company MN (4.50%), Huber Capital Management LLC (2.48%) and Northern Trust Corp (2.16%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Joachim Roeser, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.
Which institutional investors are selling Innospec stock?
IOSP stock was sold by a variety of institutional investors in the last quarter, including Huber Capital Management LLC, Tieton Capital Management LLC, Wells Fargo & Company MN, First Trust Advisors LP, Alambic Investment Management L.P., Millennium Management LLC, Eagle Asset Management Inc. and Sei Investments Co.. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.
Which institutional investors are buying Innospec stock?
IOSP stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, BlackRock Inc., Northern Trust Corp, Wasatch Advisors Inc., Russell Investments Group Ltd., Creative Planning, Acadian Asset Management LLC and Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Innospec.
How do I buy shares of Innospec?
Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Innospec's stock price today?
One share of IOSP stock can currently be purchased for approximately $76.60.
How big of a company is Innospec?
Innospec has a market capitalization of $1.86 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.
What is Innospec's official website?
How can I contact Innospec?
Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]
MarketBeat Community Rating for Innospec (NASDAQ IOSP)
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
